Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented elders

BACKGROUND: Accumulating reports have suggested that α-synuclein is involved in the pathogenesis of Alzheimer’s disease (AD). As the cerebrospinal fluid (CSF) α-synuclein has been suggested as a potential biomarker of AD, this study was set out to test whether CSF α-synuclein is associated with othe...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jie-Qiong, Bi, Yan-Lin, Shen, Xue-Ning, Wang, Hui-Fu, Xu, Wei, Tan, Chen-Chen, Dong, Qiang, Wang, Yan-Jiang, Tan, Lan, Yu, Jin-Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685645/
https://www.ncbi.nlm.nih.gov/pubmed/33228804
http://dx.doi.org/10.1186/s40035-020-00222-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685645/
https://www.ncbi.nlm.nih.gov/pubmed/33228804
http://dx.doi.org/10.1186/s40035-020-00222-1

Ejemplares similares